Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 1
1987 1
1988 2
1989 1
1990 4
1991 1
1993 2
1994 4
1995 1
1998 2
2001 2
2002 4
2003 1
2004 5
2005 1
2007 1
2008 1
2011 1
2012 1
2013 1
2015 1
2017 1
2018 4
2019 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean broadwell el[au] (4 results)?
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vázquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW 2nd, Hamburger SA, Becker MA. Sundy JS, et al. Among authors: treadwell el. JAMA. 2011 Aug 17;306(7):711-20. doi: 10.1001/jama.2011.1169. JAMA. 2011. PMID: 21846852 Clinical Trial.
Gastrointestinal manifestations of mixed connective tissue disease.
Marshall JB, Kretschmar JM, Gerhardt DC, Winship DH, Winn D, Treadwell EL, Sharp GC. Marshall JB, et al. Among authors: treadwell el. Gastroenterology. 1990 May;98(5 Pt 1):1232-8. doi: 10.1016/s0016-5085(12)90338-8. Gastroenterology. 1990. PMID: 2323516
Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
Baraf HS, Becker MA, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, Rehrig CD, Ottery FD, Sundy JS, Yood RA. Baraf HS, et al. Among authors: treadwell el. Arthritis Res Ther. 2013 Sep 26;15(5):R137. doi: 10.1186/ar4318. Arthritis Res Ther. 2013. PMID: 24286509 Free PMC article. Clinical Trial.
45 results